Mutations in PIK3CA are the most frequent mutations in the receptor tyrosine kinase-initiated pathways in colorectal cancers with BRAF mutations, as the even more frequent KRAS mutations are mutually exclusive with BRAF mutations. This evidence concerns the gene BRAF and colorectal cancer.